Jarro-Dophilus Probiotic Infant
Clinical Studies Have Demonstrated that the B. Infantis M-63 Strain Helps Establish a Healthy Microbiota in Infants and Young Children*
- 1 Billion Per Serving
- Room Temperature Stable
- U.S. Patent-Pending
- Jarro-Dophilus® Infant is formulated with Medium Chain Triglycerides (MCTs), which are naturally present in breast milk and are more easily absorbed by the newborn’s immature digestive system.*
- Dairy Free and Formulated to Reduce Clumping of Ingredients
Bifidobacterium longum subsp. infantis M-63
Bifidobacterium longum subsp. infantis (B. infantis) is associated with improved growth, the development of intestinal membrane integrity, and is critical for developing immune function.*
The Developing Intestinal Microflora of Newborns Is Up to 90% B. Infantis
B. infantis is the predominant intestinal organism found in breast-fed infants.* B. infantis M-63 was isolated from a healthy infant and clinically proven to colonize the intestines of infants.*
B. infantis is the only bacterial species able to take up and metabolize all Human Milk Oligosaccharides (HMOs) which allows B. infantis to outcompete other bacterial species.*
Jarro-Dophilus® Infant is formulated with Medium Chain Triglycerides (MCTs), which are naturally present in breast milk and are more easily absorbed by the newborn’s immature digestive system.*
For newborns to infants up to 6 months old, add 10 drops, once daily, to foods, lukewarm milk, or an infant formula. Or use as directed by your qualified healthcare professional. Shake bottle well before each use.
No Refrigeration Necessary
Does not require refrigeration and best to store in cool, dry place. Avoid storage at temperature above 77°F (25°C).
We Also Recommend
